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Cell-cycle fluctuations drive significant transcriptomic
heterogeneity in murine hematopoietic stem cells.
Additionally, deletion of Bcl11a alters the regulation of
hematopoietic stem cell quiescence, self-renewal, and
fate choice.cell, scRNA-seq enables the computational inference of
cell types, states, and regulatory programs, without priorIn this issue of Genome Biology, Tsang and colleagues
utilize the Fluidigm C1 microfluidic system to profile a
total of 180 hematopoietic stem cells (HSCs) from mice of
two different genetic backgrounds using single-cell RNA-
sequencing (scRNA-seq) [1]. They leverage these data to
interrogate the primary sources of expression variability in
HSCs, and to better understand how cellular heterogen-
eity is affected by the deletion of Bcl11a. Their findings
highlight multiple roles for this important regulator, and
point to the power of single-cell transcriptomics for disen-
tangling heterogeneous and developing systems.Heterogeneity in HSCs
Mammalian HSCs are capable of replenishing all blood
cell types. Multiple studies have used the expression of
cell surface markers to further separate the HSC com-
partment into various cell types and lineage states, which
can subsequently be tested for functional differences.
While this marker-based division has uncovered many
distinct cell types and intermediate progenitors defining
the mammalian immune system, it requires a biased pre-
selection of individual surface proteins, and fails to
characterize additional heterogeneity within each marker
subset. As a result, the molecular definition of lineage-
primed HSC subsets remains an active and exciting area
of research for multiple laboratories. For example,* Correspondence: rsatija@nygenome.org
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HSCs whose offspring exhibit a strong bias towards
myeloid differentiation [2, 3], but without a consensus
on the optimal surface markers to enrich for these cells.
Single-cell transcriptomics offers a powerful alternative
to characterizing cellular heterogeneity. By measuring
the expression of thousands of genes inside an individual
knowledge [4]. Thus, single-cell technologies represent a
promising tool for the evaluation of heterogeneous pro-
genitor populations in hematopoiesis. Indeed, while pre-
vious studies have identified key regulators for myeloid
and lymphoid development, such as the C2H2 zinc finger
transcription factor B-cell CLL/lymphoma 11A (Bcl11a)
[5], an unbiased characterization using scRNA-seq in
HSCs could reveal a large set of regulators involved in
early lineage specification. scRNA-seq studies have
already resulted in significant new insights into similar
developing systems, ranging from the blastocyst [6] to
the distal lung [7].
Cell-cycle progression drives HSC heterogeneity
Tsang and colleagues combined a series of targeted and
unbiased analyses to uncover the drivers of transcrip-
tomic heterogeneity in murine HSCs. Multiple analyses,
including the identification of variable genes, hierarch-
ical clustering, and principal component analysis, all
pointed to fluctuations in cell-cycle state as the predom-
inant source of cellular heterogeneity. By comparing
their results with a database of stage-specific cell-cycle
genes, the authors showed that they could assign indi-
vidual cells to each of the four cell-cycle stages. Similar
results have been reported across a variety of single-cell
studies [8], and this finding enabled the authors to cal-
culate the fraction of cells at each stage, a measurement
reflecting the kinetics of cell-cycle progression. For ex-
ample, with high reproducibility across replicate exper-
iments, they identified that 28 % of Bcl11a+/+ cells werearticle is distributed under the terms of the Creative Commons Attribution 4.0
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quiescent or dormant subpopulation of HSCs.
When analyzing Bcl11a-deficient cells, the authors
similarly found significant heterogeneity in cell-cycle
progression. Intriguingly, they observed that these cells
tended to be assigned (61 %) to the S and G2/M cell-
cycle phases, a more than twofold increase compared
with the wild-type controls. Consistent with this finding,
knockout cells exhibited reduced levels of known HSC
quiescence regulators, and signature genes associated
with HSC self-renewal. The authors thus proposed that
Bcl11a acts as a key regulator of HSC proliferation and
maintenance, and validated this finding using staining
for proliferation markers, as well as donor transplant-
ation experiments. The collection of these analyses dem-
onstrates an important lesson that is likely to hold true
in many single-cell studies: although cell-cycle variation
may represent an unsurprising source of cellular hetero-
geneity, changes in cycling kinetics may also reflect im-
portant differences in cellular activation state and fate
potential.
Bcl11a deletion reorganizes HSC identity and fate
After controlling for cell cycle effects, the authors discov-
ered Bcl11a-deficient HSCs split into two distinct subsets,
each of which was largely distinct from Bcl11a+/+ cells.
Consistent with the authors’ previous findings that Bcl11a-
deficient cells fail to undergo proper lymphoid development
[5], both populations exhibited a strong depletion for
the expression of genes associated with common
lymphoid progenitors. Interestingly, these additional
clusters exhibited expression patterns that were largely
consistent with distinct myeloid lineages, and further
analysis suggested that these groups may resemble
megakaryocytic-erythrocyte progenitors (MEPs) and
granulocyte-macrophage progenitors. Thus, the loss of
Bcl11a is associated with the loss of lymphoid competence,
and precocious myeloerythroid priming within HSCs.
The authors combine these findings with their previ-
ous analyses on proliferation kinetics in HSCs in order
to propose an intriguing dual role for Bcl11a. Linking
the proliferative nature of Bcl11a-deficient cells with ob-
served changes in gene expression, they suggest that the
deletion of Bcl11a leads to both the loss of lymphoid
competence among HSCs, as well as an activated in-
crease in proliferation resulting in myeloid priming, fate
restriction, and the loss of self-renewal. Notably, the au-
thors identify a subset of Bcl11a-competent cells that
partly overlap with the MEP-biased subpopulation. These
cells expressed the highest observed levels of CD41, a
marker previously associated with myeloid-biased HSCs
[2], thus hinting that the authors may have identified a
similar primed subpopulation in this study. Further inves-
tigation, potentially with larger numbers of single cells,will help to tease apart the molecular basis of lineage
priming in hematopoietic progenitors.
Concluding remarks
By complementing existing studies that have uncovered
extensive functional heterogeneity in HSCs, single-cell
transcriptomics allows unbiased interrogation of molecu-
lar heterogeneity within and across progenitor popula-
tions. Tsang and colleagues find that expression variability
in HSCs is largely driven by fluctuations in cell-cycle state,
which may enable the identification of quiescent and acti-
vated progenitors. In addition, they discover extensive
changes in population structure upon deletion of Bcl11a,
suggesting new roles for this proto-oncogene in maintain-
ing the self-renewal of lymphoid-competent HSCs. As the
scale and throughput of single-cell technologies continues
to grow, aided by exciting advances in droplet microflui-
dics [9, 10], among others, future studies will extend these
findings to reveal the compendium of intermediate pro-
genitor states, along with the key transcriptional networks,
that govern mammalian hematopoiesis.
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